Showing results (71-80 of 224) with videos related to
Sort By:
Pageof 23
Journal of Pharmaceutical and Biomedical Analysis|March 30, 2019
LC-MS/MS assay for the quantification of testosterone, dihydrotestosterone, androstenedione, cortisol and prednisone in plasma from castrated prostate cancer patients treated with abiraterone acetate or enzalutamideMerel van Nuland, Nikkie Venekamp, Willemijn M E Wouters, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 10, 2012
The bioanalysis of the major Echinacea purpurea constituents dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides in human plasma using LC-MS/MSAndrew K L Goey, Hilde Rosing, Irma Meijerman, et al.Rapid Communications in Mass Spectrometry : RCM|July 5, 2005
Quantitative analysis of the farnesyl transferase inhibitor lonafarnib (Sarasartrade mark, SCH66336) in human plasma using high-performance liquid chromatography coupled with tandem mass spectrometryNatalie M G M Appels, Maria J van Maanen, Hilde Rosing, et al.Cancer Treatment Reviews|September 1, 2006
Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: from laboratory bench to bedsideEelco de Bree, Panayiotis A Theodoropoulos, Hilde Rosing, et al.International Journal of Cancer|February 26, 2011
Individual and combined roles of CYP3A, P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) in the pharmacokinetics of docetaxelRobert A B van Waterschoot, Jurjen S Lagas, Els Wagenaar, et al.Rapid Communications in Mass Spectrometry : RCM|February 11, 2009
Validated assay for the simultaneous quantification of total vincristine and actinomycin-D concentrations in human EDTA plasma and of vincristine concentrations in human plasma ultrafiltrate by high-performance liquid chromatography coupled with tandem mass spectrometryCarola W N Damen, Trijn Israëls, Huib N Caron, et al.Pharmacotherapy|October 10, 2019
Exposure-Response Assessment of Enzalutamide and Its Major Metabolites in a Real-World Cohort of Patients with Metastatic Castration-Resistant Prostate CancerMerel van Nuland, Andries M Bergman, Hilde Rosing, et al.Cancer Chemotherapy and Pharmacology|November 27, 2002
Development of an optimal pharmacokinetic sampling schedule for rubitecan administered orally in a daily times five scheduleNadja E Schoemaker, Ron A A Mathôt, Patrick Schöffski, et al.Cancer Chemotherapy and Pharmacology|March 3, 2012
Decitabine triphosphate levels in peripheral blood mononuclear cells from patients receiving prolonged low-dose decitabine administration: a pilot studyRobert S Jansen, Hilde Rosing, Pierre W Wijermans, et al.Therapeutic Drug Monitoring|February 25, 2025
Clinical Application of Volumetric Absorptive Microsampling for Therapeutic Drug Monitoring of Oral Targeted Anticancer DrugsMarinda Meertens, Nikki Kerssemakers, Niels de Vries, et al.Pageof 23